BioSpace News Archive

Ionetix Corporation announced the signing of a supply agreement for the therapeutic radioisotope actinium-225 with Bayer.

Arcellx, Inc. and Kite, a Gilead Company, announced that the companies have expanded their existing collaboration, which was originally announced in December 2022.

Today, Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, reported financial results for the three months ending September 30, 2023 and provided a business update.

Seneca Therapeutics, Inc., announced the publication of “TEM8 in Oncogenesis” in Cells.

Pharvaris today announced the appointment of Stefan Abele, Ph.D., as Chief Technical Operations Officer.

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, today announced it will host a virtual KOL event on Monday, November 20, 2023 at 10:00 AM ET to discuss new Phase 2 ReSPECT-GBM data in recurrent glioblastoma presented at the Society for NeuroOncology (SNO) Conference.

Alkermes plc announced that it has completed the separation of its oncology business into Mural Oncology plc, a new, independent, publicly traded company.

Advanced Brain Monitoring, Inc. today announced integration of its mobile, wireless 24-channel EEG system with the Stratus EEG cloud-based clinical software platform for home or hospital seizure monitoring.

Evogene Ltd today announced its financial results for the third quarter period ended September 30, 2023.

Foundation Medicine, Inc., and Pierre Fabre Laboratories today announced a collaboration to develop Foundation Medicine’s high-quality genomic tests, FoundationOne®CDx and FoundationOne®Liquid CDx, as companion diagnostics for new targeted therapies to treat patients with non-small cell lung cancer (NSCLC).